Comparison results
| Results: Differences General | ✘B15.0 | ✘B15 | ||||||||||||||||||||||
| Related research | Analogs | Analogs | ||||||||||||||||||||||
| ||||||||||||||||||||||||
| Distinctive symptoms | ||||||||||||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 84% | 59% | ||||||||||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 71% | 50% | ||||||||||||||||||||||
| antineutrophilic cytoplasmic antibodies | 64% | 45% | ||||||||||||||||||||||
| antinuclear antibodies | 50% | 35% | ||||||||||||||||||||||
| botkin's disease in children | 28% | 23% | ||||||||||||||||||||||
| cytolysis syndrome | 20% | 16% | ||||||||||||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
